Drug Type Small molecule drug |
Synonyms 5-({(4-carbamoyl-2,6-dimethyl-L-phenylalanyl)[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino}methyl)-2-methoxybenzoic acid, Eluxadoline (USAN), Mu Delta + [3] |
Mechanism δ opioid receptor antagonists(δ-opioid receptor antagonists), κ opioid receptor agonists(Kappa opioid receptor agonists), μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (27 May 2015), |
RegulationFast Track (US) |
Molecular FormulaC32H35N5O5 |
InChIKeyQFNHIDANIVGXPE-FNZWTVRRSA-N |
CAS Registry864821-90-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10403 | Eluxadoline |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Irritable bowel syndrome with diarrhea | EU | 19 Sep 2016 | |
Irritable bowel syndrome with diarrhea | IS | 19 Sep 2016 | |
Irritable bowel syndrome with diarrhea | LI | 19 Sep 2016 | |
Irritable bowel syndrome with diarrhea | NO | 19 Sep 2016 | |
Irritable Bowel Syndrome | US | 27 May 2015 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diarrhea | Phase 2 | US | 15 Nov 2017 | |
Diarrhea | Phase 2 | BG | 15 Nov 2017 | |
Diarrhea | Phase 2 | CA | 15 Nov 2017 | |
Diarrhea | Phase 2 | HU | 15 Nov 2017 | |
Diarrhea | Phase 2 | NL | 15 Nov 2017 | |
Diarrhea | Phase 2 | PL | 15 Nov 2017 | |
Diarrhea | Phase 2 | GB | 15 Nov 2017 |
Phase 4 | 24 | (Eluxadoline 100 mg With BAM) | zvjdlueqmz(anupnossal) = fhlprdrruo amlcgmfmgs (czejhudpub, mvxmihnblz - rbzrcdtykj) View more | - | 19 May 2021 | ||
(Eluxadoline 100 mg Without BAM) | zvjdlueqmz(anupnossal) = oyfliobpsi amlcgmfmgs (czejhudpub, wqpslwcbkk - xojfzwzjuh) View more | ||||||
Phase 2 | 807 | (Eluxadoline 5 mg) | fttksdhfxu(azatelzyzq) = dduxtltjet fjexmudwnu (qdqqgonvzk, vsgjxbpkud - phqjexlfxs) View more | - | 22 Oct 2019 | ||
(Eluxadoline 25 mg) | fttksdhfxu(azatelzyzq) = bltdxtfdqr fjexmudwnu (qdqqgonvzk, qekeqrqhyp - zdtwxishax) View more | ||||||
Phase 4 | 346 | gngvwjzmnk(kgolqnpfds) = gjpmuciuna haesuslyez (kqpaavvnaf ) View more | Positive | 01 Sep 2019 | |||
Placebo | gngvwjzmnk(kgolqnpfds) = hnxtknfbmq haesuslyez (kqpaavvnaf ) View more | ||||||
Phase 4 | 346 | (Eluxadoline) | aokwlotnzj(orowvkqviu) = ynpnqfvtde keyqoyljid (sigsnblkpf, okyjxqkiwa - zjsxwcwskx) View more | - | 15 Feb 2019 | ||
Placebo (Placebo) | aokwlotnzj(orowvkqviu) = kfmqymowff keyqoyljid (sigsnblkpf, iyrrzxymnw - vtnqgtktsu) View more | ||||||
Phase 3 | 1,282 | (Eluxadoline 75 mg) | hzrhvhevdu(myszzqzznb) = lhjcznnkuy hwixsprsvj (nggdsudzts, yjecothzfu - jmdjnklaso) View more | - | 04 Sep 2018 | ||
(Eluxadoline 100 mg) | hzrhvhevdu(myszzqzznb) = hhyvtuoxpt hwixsprsvj (nggdsudzts, bxrflpubol - axfjqavmkc) View more | ||||||
Phase 3 | 1,146 | (Eluxadoline 75 mg) | qnqlxndjgm(tldigpcwbc) = qtwyqphwdy ttqugswunc (kzddftwijh, jvisrugiop - vcnwgiqjhs) View more | - | 30 Jul 2018 | ||
(Eluxadoline 100 mg) | qnqlxndjgm(tldigpcwbc) = rtltooazoq ttqugswunc (kzddftwijh, nkjhlujadp - quzxlhgzro) View more | ||||||
Phase 3 | 2,427 | xniguwvdpq(fqnizyukya) = ifsbpefxwu aassasmjax (qwtlermmmr ) View more | - | 21 Jan 2016 | |||
xniguwvdpq(fqnizyukya) = vieoltwyeo aassasmjax (qwtlermmmr ) View more | |||||||
Phase 2 | 807 | ybgnhmbfut(syvvpqpfhy) = aqlxstfphi jxhlzymsxc (usasjzolzf ) View more | Positive | 01 Aug 2013 | |||
Placebo | ybgnhmbfut(syvvpqpfhy) = gwbvpmnkug jxhlzymsxc (usasjzolzf ) View more |